FDA Approved: EVRYSDI — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA granted original approval for Evrysdi (risdiplam) from Genentech for the treatment of spinal muscular atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• EVRYSDI (risdiplam)

Snippet

ORIG AP for EVRYSDI (RISDIPLAM)